DOI: 10.4244/EIJ-D-16-00009

Wire externalisation techniques for retrograde percutaneous coronary interventions of chronic total occlusions

Kambis Mashayekhi1,2*, MD; Zivile Valuckiene3, MD; Hans Neuser2, MD; Ibrahim Akin4, MD; Nicolaus Reifart5, MD; Aurel Toma1, MD; Franz-Josef Neumann1, MD; Michael Behnes4, MD

Background

The current success rates of percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) are estimated to be above 90% by experienced CTO operators. The retrograde approach has contributed significantly to this increase. Wire externalisation represents the important final step within the retrograde approach. This expert review article aims to illustrate and explain the different kinds of techniques of wire externalisation as well as important tips and tricks. Crucial steps and bail-out techniques of wire externalisation during retrograde PCI of CTOs are summarised. Further information is given on how to avoid possible complications. This expert review addresses both the beginner and the experienced CTO operator.

INDICATIONS

Wire externalisation in retrograde PCI of CTOs means advancing the retrograde guidewire into and through the antegrade guiding catheter to serve as an antegrade route for balloon and stents.

DIFFICULTIES

Several parameters have to be taken into account prior to retrograde wiring: the length of the intracoronary loop depending on the length and tortuosity of the anatomic course of the collateral connection (CC), the diameter of the left ventricle and, last but not least, the patient’s size. Therefore, before starting the procedure, we recommend using shorter 90 cm guiding catheters, at least for the donor artery, and long retrograde (≥150 cm) microcatheters (MC) to start with for all retrograde CTO attempts in which wire externalisation is planned. As in all retrograde procedures, it is important to measure the activated clotting time (>350 sec) every 30 mins during the procedure.

Methods

Before starting the externalisation, the retrograde dedicated CTO wire first has to cross the occlusion and re-enter the correct lumen with the support of an MC positioned 2-3 cm proximal to the wire tip. Then the retrograde CTO wire may be advanced and fed into the antegrade guiding catheter (Figure 1A, Figure 1B).

Now the MC is advanced further over the conventional guidewire 2-5 cm into the antegrade guiding catheter (Figure 1C). If the MC cannot be advanced into the guide because of a hard occlusion, tortuosity or friction, an antegrade trapping balloon (2.5-3.0 mm) should be placed into the distal guide and inflated at about 8 atm to trap and fix the retrograde wire. This will increase support and allows advancing the MC into the antegrade guide.

Figure 1. Conventional wire externalisation. A retrograde MC is advanced towards the antegrade cap of the proximal CTO of the RCA (A). The retrograde guidewire engages the antegrade guiding catheter (B). The retrograde MC engages the antegrade guiding catheter (white arrow) (C). After retracting the retrograde guidewire the externalisation wire is advanced retrogradely via the externalisation route within the retrograde MC towards the antegrade guiding catheter (not shown).

Now the retrograde CTO wire is pulled and replaced by the externalisation wire via retrograde MC into the antegrade guiding catheter, finally exiting at the antegrade haemostatic valve.

Conclusions

Wire externalisation represents the important final step in the retrograde approach. Our review is addressed to both the beginner and the experienced CTO operator. The extended online version of our review outlines in more detail all the important issues dealing with the externalisation process and gives a stepwise description of wire externalisation in retrograde CTO PCI.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 13 Number 12
Dec 8, 2017
Volume 13 Number 12
View full issue


Key metrics

Suggested by Cory

Viewpoint

Feb 16, 2026
PCR: a new era dawns
Prendergast B
free

Editorial

10.4244/EIJ-D-25-01330 Feb 16, 2026
Aspirin discontinuation after ACS: timing the transition to ticagrelor monotherapy
Gragnano F and Calabrò P
free

Editorial

10.4244/EIJ-D-25-01331 Feb 16, 2026
Will the dream of "leave nothing behind" remain a utopia if we forget to optimise the systemic medical therapy?
Wykrzykowska J and Kraak R
free

State-of-the-Art

10.4244/EIJ-D-25-00598 Feb 16, 2026
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation
Oshima A et al
free

Original Research

10.4244/EIJ-D-25-00618 Feb 16, 2026
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial
Verheye S et al
open access

Flashlight

10.4244/EIJ-D-25-00431 Feb 16, 2026
A novel spacer for transcatheter treatment of tricuspid regurgitation
Barbieri F et al
open access
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved